Adaptimmune Therapeutics PLC American...





Please Login or Register

Login|Register FREE

Stock Price
Open: 13.13
Prev. Close: 13.20
Low/Hi: 12.95 - 13.42
52-Week: 4.28 - 14.63
Equity: 91,617
90-Day Avg: 604,104
Option: 33
90-Day Avg: 167
Todays Stock Vol: 34.1
20-Day (HV): 55.6
52-Week (HV): 67.0
30-Day IV: 77.6 -6.5
IV Pct Rank: 84% Elevated
Div. Yield:
Earnings: 7-Aug (Est.)
P/E Ratio:
Market Cap: 1.2 B
Short Int Pct: 0.0%
Pct Held By Inst.: 27.1%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ADAP

Adaptimmune is a clinical stage biopharmaceutical company focused on novel cancer immunotherapy products based on its T-cell receptor platform. Established in 2008, the Company aims to utilize the bodys own machinery - the T-cell - to target and destroy cancer cells by using engineered, increased affinity T-cell receptors (TCRs) as a means of strengthening natural patient T-cell responses. Adaptimmunes lead program is an affinity enhanced TCR therapeutic targeting the NY-ESO cancer antigen. Its NY-ESO TCR therapeutic candidate has demonstrated signs of efficacy and tolerability in Phase 1/2 trials in solid tumors and in hematologic cancer types. As of June 30, 2015, 85 patients had been treated with Adaptimmunes NY-ESO TCR therapeutic: 47 under Adaptimmunes IND, and 38 under a National Cancer Institute IND. In June 2014, Adaptimmune announced that it had entered into a strategic collaboration and licensing agreement with GlaxoSmithKline for the development and commercialization of the NY-ESO TCR program. The Company currently has over 150 employees.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADAP is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ADRD Invesco BLDRS Developed Markets 100 ADR Index Fund 69.1 M 6.91E+07 87 87 0.02% 0.00017 12 K 11678
ADRU Invesco BLDRS Europe Select ADR Index Fund 17.1 M 1.71E+07 76 76 0.02% 0.0002 4 K 3511
BIB ProShares Ultra Nasdaq Biotechnology 356.1 M 3.5607E+08 203 203 0.05% 0.00049971 374 K 374128
IBB iShares Nasdaq Biotechnology Index Fund 8.7 B 8.7404E+09 192 192 0.11% 0.0011 9.6 M 9634180
SBIO ALPS Medical Breakthroughs ETF 194.2 M 1.94216E+08 97 97 0.87% 0.0087 1.7 M 1689679
UBIO Proshares UltraPro Nasdaq Biotechnology 37.5 M 3.75453E+07 197 197 0.03% 0.000297701 36 K 35640

Wait, Before You Leave...

Want to Know More About ADAP Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon